ArcticZymes Signs Enzyme Supply Agreement with New England Biolabs
ArcticZymes AS, the Tromsø-based manufacturer of innovative heat-labile molecular biology enzymes, has signed a supply agreement with New England Biolabs Inc. (NEB) for the supply of Recombinant Shrimp Alkaline Phosphatase (SAP) from ArcticZymes. NEB plans to offer SAP through its global distribution network. The agreement also allows for the introduction of other ArcticZymes’ products through NEB at a later date.
“We are delighted to expand the reach for our SAP product through this agreement with New England Biolabs, one of the global leaders in the life science market. We believe our enzymes will add value to NEB’s already outstanding product portfolio, and look forward to having the NEB global distribution network greatly increase the addressable market for our products,” states Dr. Jan Buch Andersen, Managing Director at ArcticZymes.
“We are constantly seeking to add unique, quality products that further strengthen our expanding portfolio,” states Dr. Peter Nathan, Executive Director of Global Business Development at NEB. “We expect Recombinant Shrimp Alkaline Phosphatase (SAP) to be a nice addition.”
ArcticZymes AS is a subsidiary of Biotec Pharmacon ASA.
No financial or other deal terms have been disclosed.